Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2017 (2017), Article ID 1359486, 5 pages
https://doi.org/10.1155/2017/1359486
Case Report

Severe Aplastic Anemia following Parvovirus B19-Associated Acute Hepatitis

1Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
2Second Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
3Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara, Japan
4Division of Gastroenterology, Bell Land General Hospital, Sakai, Osaka, Japan

Correspondence should be addressed to Kosuke Kaji

Received 14 February 2017; Accepted 12 April 2017; Published 20 April 2017

Academic Editor: Melanie Deutsch

Copyright © 2017 Masanori Furukawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Cohen and M. M. Buckley, “The prevalence of antibody to human parvovirus B 19 in England and Wales,” Journal of Medical Microbiology, vol. 25, no. 2, pp. 151–153, 1988. View at Publisher · View at Google Scholar
  2. H. A. Kelly, D. Siebert, R. Hammond, J. Leydon, P. Kiely, and W. Maskill, “The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world,” Epidemiology and Infection, vol. 124, no. 3, pp. 449–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Arista, S. De Grazia, V. Di Marco, R. Di Stefano, and A. Craxì, “Parvovirus B19 and "cryptogenic" chronic hepatitis,” Journal of Hepatology, vol. 38, no. 3, pp. 375–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Krygier, U. P. Steinbrecher, M. Petric et al., “Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation,” World Journal of Gastroenterology, vol. 15, no. 32, pp. 4067–4069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Sun and J.-C. Zhang, “Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection,” Hepatology, vol. 55, no. 1, pp. 329–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Al-Abdwani, F. A. Khamis, A. Balkhair, M. Sacharia, and Y. A. Wali, “A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: Effectiveness of immunosuppressive therapy,” Pediatric Hematology and Oncology, vol. 25, no. 7, pp. 699–703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Dame, C. Hasan, U. Bode, and A. M. Eis-Hübinger, “Acute liver disease and aplastic anemia associated with the persistence of B19 dna in liver and bone marrow,” Pediatric Pathology & Molecular Medicine, vol. 21, no. 1, pp. 25–29, 2002. View at Publisher · View at Google Scholar
  8. A. N. Langnas, R. S. Markin, M. S. Cattral, and S. J. Naides, “Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia,” Hepatology, vol. 22, no. 6, pp. 1661–1665, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. L. D. Rogo, T. Mokhtari-Azad, M. H. Kabir, and F. Rezaei, “Human parvovirus B19: a review,” Acta Virologica, vol. 58, no. 3, pp. 199–213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. N. S. Young and K. E. Brown, “Mechanisms of disease: parvovirus B19,” New England Journal of Medicine, vol. 350, no. 6, pp. 586–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Bihari, A. Rastogi, P. Saxena et al., “Parvovirus B19 associated hepatitis,” Hepatitis Research and Treatment, vol. 2013, Article ID 472027, 9 pages, 2013. View at Publisher · View at Google Scholar
  12. Y. Yoto, T. Kudoh, K. Haseyama, N. Suzuki, and S. Chiba, “Human parvovirus B19 infection associated with acute hepatitis,” Lancet, vol. 347, no. 9005, pp. 868–869, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Mihály, A. Trethon, Z. Arányi et al., “Observations on human parvovirus B19 infection diagnosed in 2011,” Orvosi Hetilap, vol. 153, no. 49, pp. 1948–1957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. E. Brown and N. S. Young, “The simian parvoviruses,” Reviews in Medical Virology, vol. 7, no. 4, pp. 211–218, 1997. View at Google Scholar
  15. T. L. Moore, “Parvovirus-associated arthritis,” Current Opinion in Rheumatology, vol. 12, no. 4, pp. 289–294, 2000. View at Publisher · View at Google Scholar
  16. L. L. W. Cooling, T. A. W. Koerner, and S. J. Naides, “Multiple glycosphingolipids determine the tissue tropism of parvovirus B19,” Journal of Infectious Diseases, vol. 172, no. 5, pp. 1198–1205, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Morita, A. Nakashima, H. Asao, H. Sato, and K. Sugamura, “Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G1 phase,” Journal of Virology, vol. 77, no. 5, pp. 2915–2921, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. B. D. Poole, Y. V. Karetnyi, and S. J. Naides, “Parvovirus B19-induced apoptosis of hepatocytes,” Journal of Virology, vol. 78, no. 14, pp. 7775–7783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Rauff, M. Idrees, S. A. R. Shah et al., “Hepatitis associated aplastic anemia: a review,” Virology Journal, vol. 8, article 87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Andreesen, W. Brugger, C. Thomssen, A. Rehm, B. Speck, and G. W. Lohr, “Defective monocyte-to-macrophage maturation in patients with aplastic anemia,” Blood, vol. 74, no. 6, pp. 2150–2156, 1989. View at Google Scholar · View at Scopus
  21. T. Muta, Y. Tanaka, E. Takeshita et al., “Recurrence of hepatitis-associated aplastic anemia after a 10-year interval,” Internal Medicine, vol. 47, no. 19, pp. 1733–1737, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Gonzalez-Casas, L. Garcia-Buey, E. A. Jones, J. P. Gisbert, and R. Moreno-Otero, “Systematic review: hepatitis-associated aplastic anaemia—a syndrome associated with abnormal immunological function,” Alimentary Pharmacology & Therapeutics, vol. 30, no. 5, pp. 436–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Lorenz and K. Quaiser, “Panmyelophatie nach hepatitis epidemica,” Wiener Medizinische Wochenschrift, vol. 105, pp. 19–22, 1955 (German). View at Google Scholar
  24. Y. Osugi, H. Yagasaki, M. Sako et al., “Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia,” Haematologica, vol. 92, no. 12, pp. 1687–1690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Cengiz, N. Turhan, O. F. Yolcu, and S. Yilmaz, “Hepatitis associated with aplastic anemia: do CD8(+) Kupffer cells have a role in the pathogenesis?” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2438–2443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. G. Bowen, A. Warren, T. Davis et al., “Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells,” Gastroenterology, vol. 123, no. 4, pp. 1252–1264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. K. E. Brown, J. Tisdale, A. J. Barrett, C. E. Dunbar, and N. S. Young, “Hepatitis-associated aplastic anemia,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1059–1064, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Wong, N. S. Young, and K. E. Brown, “Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia,” Journal of Infectious Diseases, vol. 187, no. 10, pp. 1581–1586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Bannister, K. Miloszewski, D. Barnard, and M. S. Losowsky, “Fatal marrow aplasia associated with non-A, non-B hepatitis,” British Medical Journal (Clinical Research Ed.), vol. 286, no. 6374, pp. 1314–1315, 1983. View at Publisher · View at Google Scholar
  30. J. K. Davies and E. C. Guinan, “An update on the management of severe idiopathic aplastic anaemia in children,” British Journal of Haematology, vol. 136, no. 4, pp. 549–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Valdez, P. Scheinberg, N. S. Young, and T. J. Walsh, “Infections in patients with aplastic anemia,” Seminars in Hematology, vol. 46, no. 3, pp. 269–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Doney, W. Leisenring, R. Storb, and F. R. Appelbaum, “Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy,” Annals of Internal Medicine, vol. 126, no. 2, pp. 107–115, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Safadi, R. Or, Y. Ilan et al., “Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation,” Bone Marrow Transplantation, vol. 27, no. 2, pp. 183–190, 2001. View at Publisher · View at Google Scholar · View at Scopus